MYLK and pulmonary arterial hypertension: A study investigated MLCK inhibition with ML-7 on rat pulmonary artery smooth muscle cells and found that ML-7 treatment reduced proliferation in vitro and reduced both hemodynamic and vascular remodeling markers in a preclinical PAH murine model [56].